Antibiotic Use Following Distal and Mid-shaft Hypospadias Repair
Primary Purpose
Hypospadias
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Septra
Sponsored by
About this trial
This is an interventional treatment trial for Hypospadias focused on measuring Antibiotic Prophylaxis
Eligibility Criteria
Inclusion Criteria:
- all children between ages 6 months to 2 years under going distal or mid shaft hypospadias repair
- children of parents who give informed consent
- English speaking
- participant must be available for follow-up 3 and 12 months post-surgery
Exclusion Criteria:
- all proximal hypospadias and redo hypospadias repairs
- children who are allergic to sulfa medications
- patients who have UTI at time of surgery (proven by culture)
Sites / Locations
- Children's Hospital of Wisconsin
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Antibiotics Group
No Antibiotics Group
Arm Description
Patients randomized to this arm will receive prophylactic oral antibiotics following the surgery and catheter placement (Septra, 3 mg/kg/dose once daily), and will continue the medication for until the day before catheter removal 4-8 days post-operation.
Patients randomized to this arm will receive regular clinical care without prophylactic antibiotics, including catheter placement/removal.
Outcomes
Primary Outcome Measures
Number of Participants With Urinary Tract Infection
Urinary tract infection (UTI) will be diagnosed based on urine culture positive at 50,000CFUs per mL with one or both of the following: fever >38 Celsius, or significant fussiness and irritability with voiding per parent report. Asymptomatic bacteriuria is known and expected in this population; therefore culture positive results alone will not be sufficient to meet the definition of UTI.
Secondary Outcome Measures
Full Information
NCT ID
NCT02593903
First Posted
October 30, 2015
Last Updated
November 2, 2018
Sponsor
Medical College of Wisconsin
Collaborators
Children's Hospital and Health System Foundation, Wisconsin
1. Study Identification
Unique Protocol Identification Number
NCT02593903
Brief Title
Antibiotic Use Following Distal and Mid-shaft Hypospadias Repair
Official Title
Prophylactic Antibiotics Following Distal/Mid-shaft Hypospadias Repair: Are They Necessary?
Study Type
Interventional
2. Study Status
Record Verification Date
November 2018
Overall Recruitment Status
Completed
Study Start Date
March 4, 2014 (Actual)
Primary Completion Date
June 30, 2017 (Actual)
Study Completion Date
April 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical College of Wisconsin
Collaborators
Children's Hospital and Health System Foundation, Wisconsin
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the efficacy of prophylactic antibiotics following distal or mid-shaft hypospadias repair in influencing the rate of postoperative urinary tract infection and complications.
Detailed Description
The rationale for using prophylactic antibiotics after hypospadias surgery is to decrease the occurrence of urinary tract infections (UTIs) and complications. However, even though prophylactic antibiotics are used by some pediatric urologists, to date there has been no evidence supporting the role of prophylactic antibiotics in decreasing UTIs or complications. This is a prospective, randomized trial involving children undergoing distal or mid-shaft hypospadias repair. Subjects randomized into a group taking prophylactic dosages of antibiotics and a group not receiving post-operative antibiotics.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypospadias
Keywords
Antibiotic Prophylaxis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
67 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Antibiotics Group
Arm Type
Experimental
Arm Description
Patients randomized to this arm will receive prophylactic oral antibiotics following the surgery and catheter placement (Septra, 3 mg/kg/dose once daily), and will continue the medication for until the day before catheter removal 4-8 days post-operation.
Arm Title
No Antibiotics Group
Arm Type
No Intervention
Arm Description
Patients randomized to this arm will receive regular clinical care without prophylactic antibiotics, including catheter placement/removal.
Intervention Type
Drug
Intervention Name(s)
Septra
Other Intervention Name(s)
Bactrim, Sulfamethoxazole/trimethoprim
Primary Outcome Measure Information:
Title
Number of Participants With Urinary Tract Infection
Description
Urinary tract infection (UTI) will be diagnosed based on urine culture positive at 50,000CFUs per mL with one or both of the following: fever >38 Celsius, or significant fussiness and irritability with voiding per parent report. Asymptomatic bacteriuria is known and expected in this population; therefore culture positive results alone will not be sufficient to meet the definition of UTI.
Time Frame
4-8 days post-operation
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
2 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
all children between ages 6 months to 2 years under going distal or mid shaft hypospadias repair
children of parents who give informed consent
English speaking
participant must be available for follow-up 3 and 12 months post-surgery
Exclusion Criteria:
all proximal hypospadias and redo hypospadias repairs
children who are allergic to sulfa medications
patients who have UTI at time of surgery (proven by culture)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Travis W Groth, MD
Organizational Affiliation
Medical College of Wisconsin
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospital of Wisconsin
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53226
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
15118434
Citation
Meir DB, Livne PM. Is prophylactic antimicrobial treatment necessary after hypospadias repair? J Urol. 2004 Jun;171(6 Pt 2):2621-2. doi: 10.1097/01.ju.0000124007.55430.d3.
Results Reference
background
PubMed Identifier
29780414
Citation
Roth EB, Kryger JV, Durkee CT, Lingongo MA, Swedler RM, Groth TW. Antibiotic Prophylaxis with Trimethoprim-Sulfamethoxazole versus No Treatment after Mid-to-Distal Hypospadias Repair: A Prospective, Randomized Study. Adv Urol. 2018 Mar 26;2018:7031906. doi: 10.1155/2018/7031906. eCollection 2018.
Results Reference
derived
Learn more about this trial
Antibiotic Use Following Distal and Mid-shaft Hypospadias Repair
We'll reach out to this number within 24 hrs